December 9, 2020
credentis has been acquired by vVardis and becomes R&D powerhouse within newly formed oral care and dental group
vVardis – the recently launched personal oral care brand by Dres Abivardi – has acquired credentis. credentis and vVardis previous partnership has already yielded the unique vVardis oral care product line, and now credentis will become the research and development department within vVardis.
Following the acquisition of credentis by vVardis, both the professional dental CURODONT™ line and the oral care vVardis products – both with the proprietary CUROLOX® & WX Technology – will form one oral care powerhouse. Within the newly formed partnership, credentis leadership team will continue to run credentis in order to accelerate the research and development of revolutionary oral care and dental products. For the credentis investors the acquisition by vVardis represents a successful exit, concluding a nearly decade long collaboration.
“I am overjoyed that we managed to establish credentis as an innovative dental and oral care company, that has become a successful investment case. Furthermore, with this acquisition the value generated will remain and support growth in Switzerland.”, says Dr Erich Platzer, former President of the Board of Directors of credentis, and lead investor for the business angel group, StartAngelsNetwork.
“This is a dream coming true – after 10 years of scientific research and development of our unique CUROLOX® TECHNOLOGY and the CURODONT™ products, we will take the next step – establishing the credentis and vVardis products in the dental and OTC markets.”, says Dr Dominik Lysek, CEO of credentis.
“For us, the combination of credentis’ scientific expertise and innovation, and our unique vVardis brand based on our expertise in Dentistry and Oral Care makes the perfect team to revolutionize the oral care and dental market with the best products possible.”, say the Dres Haleh and Golnar Abivardi, CEOs of vVardis.